Insider Buying, FDA Buzz and AI Gold Rush: Six Stocks Investors Should Not IgnoreAinos (NASDAQ:AIMD), NeOnc Technologies Holdings (NASDAQ:NTHI), enGene Therapeutics (NASDAQ:ENGN), CuriosityStream (NASDAQ:CURI), Tecogen (NYSEAMERICAN:TGEN) and Exascale Labs Holdings (NASDAQ:XLAB) are offering compelling narratives.